US health fraud costs GlaxoSmithKline £1.9bn

Drugs firm GlaxoSmithKline will pay three billion dollars (£1.9bn) in fines after admitting to the largest healthcare fraud in US history.

The UK's largest pharmaceutical company was accused of bribing doctors in America to prescribe medicines for unapproved uses, with potentially dangerous side effects.